The clinical research industry has long hungered for a nextlevel
innovation to make paper all but obsolete in clinical
research. In eSource, that innovation has finally arrived. After
all, while EDC has brought significant gains to clinical research
in terms of speed and data integrity, it has not eliminated
paper entirely. eSource enables researchers to finish the job,
and may constitute the most significant cutting out of the
middle man in the history of the industry. Mike Novotny and

Nick O’Brien, at Medrio, explain the benefits and beneficiaries
of eSource.

https://www.jforcs.com/7/wp-content/uploads/2016/11/eSource…pdf